Table 4.

Frequency of initial treatment emergent events by randomized treatment group among those reporting at least one adverse event^*

Event	Metronidazole 500mg n(%)	Tinidazole 1g n(%)	Tinidazole 500mg n(%)	p value
Yeast infection	32 (29.3)	27 (24.5)	33 (25.0)	0.67
Nausea/vomiting	22 (20.2)	34 (30.9)	26 (19.7)	0.08
Bad taste	12 (11.0)	46 (41.8)	20 (15.2)	<0.001
Diarrhea	4 (3.7)	6 (5.5)	1 (0.8)	0.10
Anorexia	1 (0.8)	5 (4.5)	7 (5.3)	0.17
Headache	16 (14.7)	27 (24.5)	22 (16.7)	0.13
Total Number of Subjects with at Least 1 Adverse Event	109	110	132

^*Subjects can experience more than one adverse event; the percents reperesent the number of subjects with that incident event out of the total number of individuals in each treatment group who experienced at least one adverse event.